63 results
Page 3 of 4
424B5
4jczs mrh
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
ze4jgc2tlbgva9 582q
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
uri4i7ays1d
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99
fxk2nooq9f fhung
8 Jan 14
Current report (foreign)
12:00am
6-K
EX-99
ter3hdxrayii
23 Oct 13
Current report (foreign)
12:00am
6-K
EX-99
iu0zobzz
17 Sep 13
BioLineRx Announces Receipt of a Notice of Allowance
12:00am
424B3
fujv0 kbjwz
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
ttmfjm
7 May 13
BioLineRx Reports First Quarter 2013 Results
12:00am
6-K
EX-99
mjy1z9 6sngk
30 Apr 13
Current report (foreign)
12:00am
6-K
EX-99
hobf68e55cn87md
29 Apr 13
Current report (foreign)
12:00am
6-K
EX-99
t96pskz57stu1636vph
28 Feb 13
Current report (foreign)
12:00am
424B5
4z7pty7qpucn0nq6jk
6 Feb 13
Prospectus supplement for primary offering
12:00am
6-K
EX-99
dmfkn1ryv351ri7zyr
16 Oct 12
BioLineRx Announces Successful Completion of Pre-Clinical
12:00am
424B3
vuz8uhhscbneswy
15 Oct 12
Prospectus supplement
12:00am
F-1
qd5h6e67fl8mrk7
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99.1
xret4lca3s2utho3ka
4 Sep 12
Current report (foreign)
12:00am
424B3
igoc6 njb5wutp663e
28 Mar 12
Prospectus supplement
12:00am
20-F
b2cq3o
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-1
5xbtz4paq5p6 nqz5
26 Sep 11
BioLineRx to Present Data from the Successfully Completed
12:00am